1
|
Demicco EG, Fritchie KJ and Han A: WHO
classification of tumours: soft tissue and bone tumours. 5th ed.
International Agency for Research on Cancer; Lyon, France: 2020
|
2
|
de Pinieux G, Karanian M, Loarer FL,
Guellec SL, Chabaud S, Terrier P, Bouvier C, Batistella M, Neuville
A, Robin YM, et al: Nationwide incidence of sarcomas and connective
tissue tumors of intermediate malignancy over four years using an
expert pathology review network. PLoS One. 16:e02469582021.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Kinslow CJ and Wang TJC: Incidence of
extrameningeal solitary fibrous tumors. Cancer. 126:40672020.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Machado I, Nieto Morales MG, Cruz J,
Lavernia J, Giner F, Navarro S, Ferrandez A and Llombart-Bosch A:
Solitary fibrous tumor: Integration of clinical, morphologic,
immunohistochemical and molecular findings in risk stratification
and classification may better predict patient outcome. Int J Mol
Sci. 22:94232021. View Article : Google Scholar : PubMed/NCBI
|
5
|
Kim JM, Choi YL, Kim YJ and Park HK:
Comparison and evaluation of risk factors for meningeal, pleural,
and extrapleural solitary fibrous tumors: A clinicopathological
study of 92 cases confirmed by STAT6 immunohistochemical staining.
Pathol Res Pract. 213:619–625. 2017. View Article : Google Scholar : PubMed/NCBI
|
6
|
Akaike K, Kurisaki-Arakawa A, Hara K,
Suehara Y, Takagi T, Mitani K, Kaneko K, Yao T and Saito T:
Distinct clinicopathological features of NAB2-STAT6 fusion gene
variants in solitary fibrous tumor with emphasis on the acquisition
of highly malignant potential. Hum Pathol. 46:347–356. 2015.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Mearini E, Cochetti G, Barillaro F,
Fatigoni S and Roila F: Renal malignant solitary fibrous tumor with
single lymph node involvement: Report of unusual metastasis and
review of the literature. Onco Targets Ther. 7:679–685.
2014.PubMed/NCBI
|
8
|
Yang XJ, Zheng JW, Ye WM, Wang YA, Zhu HG,
Wang LZ and Zhang ZY: Malignant solitary fibrous tumors of the head
and neck: A clinicopathological study of nine consecutive patients.
Oral Oncol. 45:678–682. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Yang Y, Miller CR, Clement C, Hes O and
Eyzaguirre E: Malignant solitary fibrous tumour of the kidney with
lymph node and liver metastases. Pathology. 49:450–453. 2017.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Demicco EG, Wagner MJ, Maki RG, Gupta V,
Iofin I, Lazar AJ and Wang WL: Risk assessment in solitary fibrous
tumors: Validation and refinement of a risk stratification model.
Mod Pathol. 30:1433–1442. 2017. View Article : Google Scholar : PubMed/NCBI
|
11
|
Demicco EG, Park MS, Araujo DM, Fox PS,
Bassett RL, Pollock RE, Lazar AJ and Wang WL: Solitary fibrous
tumor: A clinicopathological study of 110 cases and proposed risk
assessment model. Mod Pathol. 25:1298–1306. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Yuan X, Liu Y, Wang X, Chen Y, Zhang L and
Wei J: Clinicopathological analysis of retroperitoneal solitary
fibrous tumours: A study of 31 cases. Histol Histopathol. 37:43–50.
2022.PubMed/NCBI
|
13
|
Gholami S, Cassidy MR, Kirane A, Kuk D,
Zanchelli B, Antonescu CR, Singer S and Brennan M: Size and
Location are the most Important risk factors for malignant behavior
in resected solitary fibrous tumors. Ann Surg Oncol. 24:3865–3871.
2017. View Article : Google Scholar : PubMed/NCBI
|
14
|
Matsuishi K, Eto K, Morito A, Hamasaki H,
Morita K, Ikeshima S, Horino K, Shimada S and Baba H:
Retroperitoneal fibrous tumor recurring as lung metastases after 10
years: A case report. Surg Case Rep. 7:1272021. View Article : Google Scholar : PubMed/NCBI
|
15
|
Ito H, Fukuda M, Imamura Y and Fuse H: A
malignant solitary fibrous tumor in the retroperitoneum. Int J Clin
Oncol. 13:173–175. 2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Vivero M, Doyle LA, Fletcher CD, Mertens F
and Hornick JL: GRIA2 is a novel diagnostic marker for solitary
fibrous tumour identified through gene expression profiling.
Histopathology. 65:71–80. 2014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ouladan S, Trautmann M, Orouji E, Hartmann
W, Huss S, Büttner R and Wardelmann E: Differential diagnosis of
solitary fibrous tumors: A study of 454 soft tissue tumors
indicating the diagnostic value of nuclear STAT6 relocation and
ALDH1 expression combined with in situ proximity ligation assay.
Int J Oncol. 46:2595–2605. 2015. View Article : Google Scholar : PubMed/NCBI
|
18
|
Creytens D, Libbrecht L and Ferdinande L:
Nuclear expression of STAT6 in dedifferentiated liposarcomas with a
solitary fibrous tumor-like morphology: A diagnostic pitfall. Appl
Immunohistochem Mol Morphol. 23:462–463. 2015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Bieg M, Moskalev EA, Will R, Hebele S,
Schwarzbach M, Schmeck S, Hohenberger P, Jakob J, Kasper B, Gaiser
T, et al: Gene expression in solitary fibrous tumors (SFTs)
correlates with anatomic localization and NAB2-STAT6 gene fusion
variants. Am J Pathol. 191:602–617. 2021. View Article : Google Scholar : PubMed/NCBI
|
20
|
Nonaka H, Kandori S, Nitta S, Shiga M,
Nagumo Y, Kimura T, Kawahara T, Negoro H, Hoshi A, Kojima T, et al:
Case report: Molecular characterization of aggressive malignant
retroperitoneal solitary fibrous tumor: A case study. Front Oncol.
11:7369692021. View Article : Google Scholar : PubMed/NCBI
|
21
|
Park HK, Yu DB, Sung M, Oh E, Kim M, Song
JY, Lee MS, Jung K, Noh KW, An S, et al: Molecular changes in
solitary fibrous tumor progression. J Mol Med (Berl). 97:1413–1425.
2019. View Article : Google Scholar : PubMed/NCBI
|
22
|
de Bernardi A, Dufresne A, Mishellany F,
Blay JY, Ray-Coquard I and Brahmi M: Novel therapeutic options for
solitary fibrous tumor: Antiangiogenic therapy and beyond. Cancers
(Basel). 14:10642022. View Article : Google Scholar : PubMed/NCBI
|